VERTEX PHARMACEUTICALS INC / MA Share-Based Compensation 2008-2026 | VRTX
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is VERTEX PHARMACEUTICALS INC / MA's current share-based compensation?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual share-based compensation for 2025 was $685.9M, a 1.80% decline from 2024. VERTEX PHARMACEUTICALS INC / MA share-based compensation for the quarter ending March 31, 2026 was $166.4M.
What was VERTEX PHARMACEUTICALS INC / MA's share-based compensation in 2024?
VERTEX PHARMACEUTICALS INC / MA annual share-based compensation for 2024 was $698.5M, a 20.18% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's share-based compensation in 2023?
VERTEX PHARMACEUTICALS INC / MA annual share-based compensation for 2023 was $581.2M, a 18.30% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year share-based compensation CAGR?
VERTEX PHARMACEUTICALS INC / MA share-based compensation grew at a compound annual growth rate (CAGR) of 9.81% from FY2020 to FY2025, going from $429.5M to $685.9M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $685.9M | -1.8% | 10-K |
| FY2024 | $698.5M | +20.2% | 10-K |
| FY2023 | $581.2M | +18.3% | 10-K |
| FY2022 | $491.3M | +11.3% | 10-K |
| FY2021 | $441.4M | +2.8% | 10-K |
| FY2020 | $429.5M | +19.1% | 10-K |
| FY2019 | $360.5M | +10.9% | 10-K |
| FY2018 | $325.0M | +10.8% | 10-K |
| FY2017 | $293.2M | +21.9% | 10-K |
| FY2016 | $240.6M | +4.2% | 10-K |
| FY2015 | $231.0M | +30.1% | 10-K |
| FY2014 | $177.5M | +39.5% | 10-K |
| FY2013 | $127.3M | +11.4% | 10-K |
| FY2012 | $114.3M | -3.3% | 10-K |
| FY2011 | $118.2M | +29.7% | 10-K |
| FY2010 | $91.1M | +5.1% | 10-K |
| FY2009 | $86.7M | +49.6% | 10-K |
| FY2008 | $58.0M | - | 10-K |